rs1553262438
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_020435.4(GJC2):c.141C>G(p.Tyr47*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_020435.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJC2 | NM_020435.4 | c.141C>G | p.Tyr47* | stop_gained | Exon 2 of 2 | ENST00000366714.3 | NP_065168.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Spastic paraplegia Pathogenic:1
This sequence change results in a premature translational stop signal in the GJC2 gene (p.Tyr47*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 393 amino acids of the GJC2 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with GJC2-related disease. Different truncation variants that lie downstream of this variant have been reported in individuals affected with Pelizaeus-Merzbacher-like disease (PMID: 18094336, 20513814). This suggests that deletion of this region of the GJC2 protein is causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at